ProVision Healthcare, Knoxville, is getting help from Cardinal Health to manage and operate ProVision’s cyclotron. The agreement will enable Cardinal Health to further expand its manufacturing capabilities of its molecular imaging biomarkers in the southeastern region of the U.S.

The Knoxville cyclotron facility is part of the East Tennessee Healthcare Center (ETHC). Cardinal Health also operates a nuclear pharmacy in Knoxville, where it dispenses PET imaging agents. The new ProVision facility will also support clinical trials for developing new PET agents.

John Rademacher, president of Cardinal Health’s Nuclear and Pharmacy Services, said in the press announcement, “Our agreement will play a key role in enabling us to bring this important modality to patients in Tennessee and throughout the southeast United States.”

Visit Cardinal Health for more information.

(Source: Press Release)